The KLK6 gene (previously known as zyme, protease M, neurosin, PRSS6) was originally cloned based on its lower expression in metastatic breast cancer compared to primary cancer and normal tissue (Anisowicz et al, 1996). The gene discussed is KLK6; the disease is breast cancer.